Lv11
48 积分 2025-02-05 加入
A small molecule–kinase interaction map for clinical kinase inhibitors
5小时前
已完结
Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor
6个月前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
7个月前
已完结
Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity
7个月前
已完结
H3K27me3 conditions chemotolerance in triple-negative breast cancer
8个月前
已完结
Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors
8个月前
已完结
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
9个月前
已完结
Update on the Development of MNK Inhibitors as Therapeutic Agents
9个月前
已完结
TAM family kinases as therapeutic targets at the interface of cancer and immunity
9个月前
已完结
UNC5293, a potent, orally available and highly MERTK-selective inhibitor
9个月前
已完结
皖公网安备34019202002308
